Nov 11, 2021
Mary Van Beusekom | News Writer | CIDRAP NewsNov 11, 2021Two doses offer 77.8% efficacy against symptomatic COVID-19 but about 65% against the Delta variant.Read More
Mary Van Beusekom | News Writer | CIDRAP NewsNov 11, 2021Two doses offer 77.8% efficacy against symptomatic COVID-19 but about 65% against the Delta variant.Read More